Biotech Showcase is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Rohan Palekar
CEO at 89Bio

Profile

Rohan Palekar is a seasoned C-suite executive with over 25 years of experience in the biopharmaceutical industry. Rohan is the CEO of 89Bio, a clinical-stage company focused on developing treatments for non-alcoholic steatohepatitis (NASH) and other liver and metabolic disorders. Previously, Rohan was the president and CEO of Avanir Pharmaceuticals (2015-2017) after serving as its EVP-Chief Operating Officer (2015). Rohan joined Avanir in 2012 as Chief Commercial Officer (CCO) and as part of the senior leadership team led the organization through a dynamic growth phase. Avanir was acquired by Otsuka Pharmaceuticals in 2015. Prior to Avanir, Rohan served as the CCO of Medivation where he oversaw commercial, medical affairs, CMC & manufacturing. Earlier in his career, Rohan spent 16 years at Johnson & Johnson in various senior commercial and strategic management roles including worldwide VP of immunology. Rohan holds an MBA from the Amos Tuck School at Dartmouth College and a BA/BS in law and accounting from the University of Bombay.

Rohan Palekar's Network

Agenda Sessions

  • NASH MOAs: A highly competitive playing field - Hilton Union Square

    ,

Speakers at this event